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Abstract
Of 455 ultrasonography-guided vacuum-assisted core needle biopsy (VAB) cases of small breast lesions,
ﬁne-needle aspiration cytology (FNAC) was performed before VAB in 248 cases [54.5%] yielding inconclusive
results in 133 cases [53.6%]. Excisional biopsy was performed in 17 benign VAB cases, because of FNAC
overdiagnosis in 6 cases [35%]. Pathological, not cytological, examination should be the initial diagnostic
approach.
Background: In recent years, pathological diagnoses have been increasingly required, especially in small breast le-
sions, because malpractice lawsuits concerning erroneous cytological diagnoses have been commonly reported.
Here, we retrospectively evaluated the signiﬁcance of FNAC and VAB for small breast lesions using ultrasonography
guidance. Patients and Methods: A total of 1383 cases for which ultrasonography-guided VAB was performed
between June 1996 and December 2012 were reviewed. Of these, 455 small breast lesions (239 nonpalpable and 216
nonmass lesions) were included in the study. Results: Ultrasonography-guided FNAC was performed before VAB in
248 cases (54.5%). In 133 cases (53.6%), the results of FNAC were inconclusive. Pathological examinations using
VAB revealed malignant and benign lesions in 199 and 256 cases, respectively. Of the 256 benign cases, we per-
formed excisional biopsy in 17 cases (6.6%) and repeated VAB in 8 cases (3.1%). Excisional biopsy revealed ma-
lignant lesions in 2 cases. The reason for excisional biopsy was overdiagnosis using FNAC in 6 cases (35%). In all
cases of repeated VAB, the pathological diagnosis was benign. The reason for repeated VAB was excision of the
lesions in 5 cases (62.5%). The false positive and false negative rates of FNAC were 16.7% and 3.4%, respectively,
whereas those of VAB were 0% and 1.0%, respectively. Conclusion: Cytology ﬁndings for small breast lesions should
be considered only when imaging and cytology indicate benign lesions. Therefore, pathological examination without
cytological examination should be the initial approach.
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It is often difﬁcult to determine whether small lesions are ma-
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itive diagnosis and is inevitably performed using image-guided
techniques. It is well known that ﬁne-needle aspiration
cytology (FNAC) has high sensitivity and speciﬁcity for mass
lesions; however, in terms of low-grade malignancies and papil-
lary lesions, diagnosis using FNAC might be difﬁcult.1-4 The
need for pathological diagnoses has increased in recent years,
primarily because malpractice lawsuits concerning inaccurate
cytological diagnoses have become common. Here, we reviewed
the medical records of small breast lesion cases diagnosed using
ultrasonography-guided vacuum-assisted core needle biopsy
(VAB) at our institution, and retrospectively evaluated the sig-
niﬁcance of FNAC and VAB with ultrasonography guidance for
small breast lesions.Clinical Breast Cancer February 2015 - e23
Table 2 Pathological Results of Vacuum-Assisted Core
Needle Biopsy
Status Diagnosis Value
Malignant Invasive ductal carcinoma 124
Table 1 Indications for VAB
Indications for VAB Value
Indeterminate Diagnosis According to Imaging
Findings
175
Indeterminate Diagnosis According to FNAC 106
Inconsistent Diagnoses Between FNAC and Imaging
Findings
92
Conﬁrmation of Benign Tumors 24
Inadequate Cases for FNAC 23
Removal of Benign Tumors 8
Biological Marker Identiﬁcation Before Primary
Therapy
6
Others 21
Abbreviations: FNAC ¼ ﬁne needle aspiration cytology; VAB ¼ vacuum-assisted core needle
biopsy.
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e24 -Patients and Methods
A total of 1383 cases of ultrasonography-guided VAB performed
at our institution between June 1996 and December 2012 were
reviewed. Of these cases, 455 cases of small breast lesions (239
nonpalpable lesions and 216 nonmass lesions) were included in our
analyses, including 36 cases of magnetic resonance imaging/
multidetector-row computed tomography-detected lesions.
Ultrasonographic examinations were performed using a LOGIC
500 (GE Healthcare, Waukesha, WI) using an 11-MHz linear
transducer before November 2011, and using an Aplio MX
(Toshiba, Tokyo, Japan) using an 8-MHz linear transducer since
November 2011. We performed VAB with ultrasonography guid-
ance using 11-gauge probes (Mammotome Biopsy system, Biopsys
Medical Inc, Irvine, CA) for deﬁnitive pathological diagnosis.
Ethical Considerations
This study was approved by the institutional review board of
Kawaguchi Municipal Medical Center.
Results
The mean age of the 455 included patients was 52.7 years (range,
24-88 years). Ultrasonography-guided FNAC was performed before
VAB in 248 cases (54.5%).
The cytological diagnoses were malignancy, suspected malig-
nancy, indeterminate, benign, or normal, and inadequate in 72,
21, 85, 43, and 27 cases, respectively. Of these cytological results,
the ﬁnal pathological diagnosis was malignant in 70 of 72, 15 of
21, 32 of 85, 3 of 43, and 6 of 27 cases, respectively (Figure 1).
Accordingly, the true positive, true negative, false positive, and
false negative rates for the 136 cases (excluding the indeterminate
and inadequate cases) using FNAC were 96.6%, 83.3%, 16.7%,
and 3.4%, respectively.
Indications for VAB included indeterminate imaging ﬁndings
(175 cases), indeterminate ﬁndings using FNAC (106 cases),
inconsistent imaging and FNAC ﬁndings (92 cases), conﬁrmation
of benign lesions (24 cases), inadequate FNAC ﬁndings (23 ﬁnd-
ings), removal of the benign tumor (8 cases), biological marker
identiﬁcation before primary therapy (6 cases), and other (21 cases)
(Table 1). The results of the pathological examinations of the VAB
specimens are summarized in Table 2.Figure 1 Pathological Diagnosis Versus Fine Needle Aspiration
Cytology (FNAC) Results
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post-VAB excisional biopsy in 17 cases. The reasons for this second
pathological examination were malignant or suspicious ﬁndings
for malignancy using FNAC (8 cases), inconsistent imaging and
FNAC ﬁndings (4 cases), and other (5 cases). Excisional biopsy
revealed malignancy in 2 of these 17 cases. In 1 of the 2 cases, the
malignant lesion was mixed with benign lesions, suggesting that the
VAB and excisional biopsy results were indeed correct. The other
case was a low-grade malignancy and we were unable to diagnose
this on the basis of the VAB specimen. Moreover, we reperformed
VAB in 8 of the original 256 cases, and these were all diagnosed as
benign according to the ﬁrst and second VAB. Excision of the lesion
was the primary reason for the second VAB (5 cases), followed by
inconsistencies in the imaging ﬁndings (2 cases), and suspected
malignancy using FNAC (1 case). In accordance with the cytolog-
ical diagnoses, the pathological diagnosis in all 8 cases was benign
after the ﬁrst and second VAB (Figure 2). The true positive, true
negative, false positive, and false negative rates of VAB were 99%,Invasive lobular carcinoma 1
Ductal carcinoma in situ 71
Others 3
High-Risk Lesion Atypical ductal hyperplasia 2
Atypical lobular hyperplasia 1
Benign Adenosis 56
Fibroadenoma 48
Intraductal papilloma 45
Hyperplasia 28
Fibrous disease 24
Fibrocystic changes 19
Chronic mastitis 5
Benign nonspeciﬁc 16
Other benigna 12
aIncludes columnar hyperplasia, hamartoma, adenoma, granuloma, and leiomyoma.
Figure 2 Further Treatments and Pathological Results for Cases Classiﬁed as Benign Using Vacuum-Assisted Core Needle Biopsy
(VAB)
Abbreviation: FNAC ¼ ﬁne needle aspiration cytology.
Table 3 Accuracy Rates of FNAC and VAB
Result FNAC, % VAB, %
True Positive 96.6 99.0
True Negative 83.3 100.0
False Positive 16.7 0.0
False Negative 3.4 1.0
Abbreviations: FNAC ¼ ﬁne needle aspiration cytology; VAB ¼ vacuum-assisted core needle
biopsy.
Satoko Nakano et al100%, 0%, and 1.0%, respectively (Table 3). The mean follow-up
duration was 43 months (range, 3-4889 days).
Discussion
Even though tiny breast lesions can usually be detected using
various imaging modalities, they are not always typical in appear-
ance, and might need cytological or pathological examination for
deﬁnitive diagnosis. Previously, cytological examination was mainly
performed as an initial direct diagnostic method for all breast lesions
to decide on the optimal management policy.5 However, it is
difﬁcult to determine whether tiny breast lesions are benign or
malignant on the basis of imaging ﬁndings alone, and for such cases,
pathological examinations are needed for a deﬁnitive diagnosis, even
when the cytological ﬁndings indicate malignancy.
Here, we performed cytological examinations in 248 cases
[54.5%] of a total of 455 small breast lesions before VAB. Incon-
clusive or indeterminate results were noted in 106 cases [42.7%]
and inadequate ﬁndings were observed in 27 cases [10.9%].
Accordingly, the true negative (83.3%) and false positive (16.7%)
rates were not satisfactory. Cytology for tiny breast lesions is only
signiﬁcant when imaging and cytological ﬁndings are consistent and
the result is benign, and therefore, we believe that pathological
examination without cytological examination should be considered
as the initial approach.
Although the pathological diagnoses using VAB were benign, we
performed excisional biopsy and repeated VAB in 17 [6.6%] and 8
cases [3.1%] respectively. Overdiagnosis based on the cytology
ﬁndings was the main reason for excisional biopsy and repeated
VAB after benign results in 6 cases [35%] and 1 case [12.5%]
respectively, and the false negative rate was found to be 1.0%. Thus,
omitting cytology for small lesions could prevent excessive biopsy.
In this study, 2 out of 17 excisional biopsy cases [11.8%] and 2
out of 256 VAB benign cases [0.78%] were later found to be ma-
lignant. Although this indicates false negative results for VAB, thesampling of the lesions was determined to be adequate, with 1 of the
2 false negative cases consisting of mixed benign and malignant
tumor tissues and the other case being a low-grade malignancy.
Thus, these were not true false negative results of VAB.
Although the availability of instruments and the examiner’s level
of knowledge and preferred technique should be considered, the use
of VAB or core needle biopsy (CNB) is currently controversial. We
chose VAB because the manner in which the VAB probe samples the
lesion can be easily and accurately identiﬁed during biopsy, and
because a tissue sample can be obtained with a single insertion.
Moreover, the samples acquired using VAB are much larger than
samples acquired using CNB. In general, VAB is the preferred
method for atypical lesions, low-grade malignancies, and rare tumors.
It has been reported that the false negative rate of CNB is
1.1% to 3.3%,6-14 whereas the corresponding rate of VAB is 0.6%
to 3.5%.15-18 Among lesions with ultrasonographyehistologic
discordance, 21.4% are upgraded in the pathological diagnosis after
VAB, according to Li et al.19 Furthermore, it has also been reported
that VAB might be valuable for deﬁnitive diagnosis when patho-
logical results with CNB are discordant with imaging ﬁndings.19-21
Accordingly, the use of VAB is supported by many physicians,
especially for small lesions.14,22,23 However, we have to keep in
mind that VAB is based on the same concept as CNB: a partialClinical Breast Cancer February 2015 - e25
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e26 -sampling of the tumor. If the pathological results are discordant
with the imaging ﬁndings, we have to review whether the acquisi-
tion of the lesion was adequate. In fact, here we reported very few
cases in which excisional biopsy revealed malignancy after VAB.
Hahn et al reported in their study that excisional biopsy is the
preferred technique for the pathological diagnosis of radial scar and
atypical ductal hyperplasia, because VAB has not been proven to be
sufﬁcient for diagnosis of these lesions.24 The reasons for false
negative ﬁndings include technical difﬁculty in acquisition of the
lesion, difﬁculty in pathological diagnosis, the lesion being too small
for pathological diagnosis, and malignant lesions being surrounded
by benign lesions, among others. In general, the smaller the lesion,
the more difﬁcult the pathological diagnosis.
In many cases, tiny breast lesions are not highly aggressive, and
underdiagnosis is thus a concern. In follow-up of these cases, adverse
effects that endanger the patients’ lives can be avoided. Only in
complex ﬁbroadenomas, overdiagnosis is an issue.25 However, al-
though eliminating overdiagnosis and underdiagnosis is ideal, it is
difﬁcult, even with VAB. According to the US Preventive Services
Task Force, benign or normal cases that require further examination
are classiﬁed as false positive. False positive results subject the patients
to further imaging, cytological, and pathological examinations, and
increased mental stress.26 Hence, diagnosing and treating ductal
carcinoma in situ and other low-grade lesions might be considered
overtreatment, and the patients’ preferences, taking into account the
potential ﬁnancial costs, adverse events, and predictive outcomes,
should thus be considered when treatment decisions are made.27,28
This study had some limitations. First, it was a retrospective
single-center study. Second, these lesions are generally not highly
aggressive. Even if the results of VAB are negative for cancer, follow-
up is still required.
Conclusion
We showed that FNAC is associated with a relatively high rate of
false positive results, whereas VAB is associated with high true
positive and true negative rates and a very low false positive rate.
Thus, we believe that pathological, and not cytological, examination
is highly reliable and should be the initial approach for the diagnosis
of small breast lesions.
Clinical Practice Points
 Diagnosis using FNAC might be difﬁcult for low-grade malig-
nancies and papillary lesions.
 Omitting cytology for small lesions could prevent the excessive
performance of biopsy.
 Pathological examination should be the initial direct diagnostic
approach for small breast lesions.
 Vacuum-assisted CNB for pathological diagnosis is a highly
reliable technique associated with high true positive and true
negative rates and a very low false positive rate.
 By reducing the number of false positive results, the need for
patients to undergo further examinations is decreased, thereby
resulting in reduced stress and anxiety for the patients.Acknowledgments
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